pirenzepine has been researched along with Pancreatic Fistula in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Pancreatic Fistula: Abnormal passage communicating with the PANCREAS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In conscious dogs with gastric and pancreatic fistulas, we compared the action of different doses of telenzepine (ranging from 9 to 243 nmol kg-1 h-1 i." | 3.68 | Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs. ( Küppers, U; Singer, MV; Teyssen, S, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singer, MV | 1 |
| Teyssen, S | 1 |
| Küppers, U | 1 |
1 other study available for pirenzepine and Pancreatic Fistula
| Article | Year |
|---|---|
Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs.
Topics: Animals; Dogs; Duodenum; Female; Gastric Fistula; Pancreas; Pancreatic Fistula; Pancreatic Juice; Pa | 1991 |